On December 8, 2022, Shenzhen Hemu Gene Biotechnology Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.13 CNY | -0.19% | +5.52% | -14.31% |
04-26 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.31% | 2.16B | |
-20.85% | 10.91B | |
+46.92% | 3.3B | |
-33.49% | 2.19B | |
-27.95% | 1.5B | |
+29.77% | 1.09B | |
-3.28% | 737M | |
-27.58% | 404M | |
-46.63% | 386M | |
+17.30% | 342M |
- Stock Market
- Equities
- 300676 Stock
- News BGI Genomics Co., Ltd.
- Shenzhen Hemu Gene Biotechnology Co., Ltd. announced that it has received CNY 30 million in funding from BGI Genomics Co., Ltd.